Search company, investor...

Founded Year

2015

Stage

Series G | Alive

Total Raised

$906.13M

Valuation

$0000 

Last Raised

$235M | 3 yrs ago

Revenue

$0000 

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

-25 points in the past 30 days

About Lyra Health

Lyra Health specializes in providing workforce mental health care solutions within the healthcare industry. The company offers evidence-based mental health care, utilizing AI-powered provider matching and a digital platform to deliver personalized support and treatment. Lyra Health's services cater to a diverse range of mental health needs, ensuring accessible and effective care for individuals and teams. It was founded in 2015 and is based in Burlingame, California.

Headquarters Location

287 Lorton Avenue

Burlingame, California, 94010,

United States

800-505-5972

Loading...

ESPs containing Lyra Health

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTH ➡MARKET STRENGTH ➡LEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare & Life Sciences / Care Delivery & Navigation Tech

The tele-psychiatry providers market utilizes technology to provide remote mental health services to patients. This market includes telehealth platforms, virtual clinics, and online therapy services that offer psychiatric consultations, therapy, and medication management. The market is driven by increasing demand for convenient and accessible mental healthcare services, as well as a shortage of me…

Lyra Health named as Leader among 15 other companies, including Talkspace, Spring Health, and Uwill.

Loading...

Research containing Lyra Health

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Lyra Health in 6 CB Insights research briefs, most recently on Sep 13, 2023.

Expert Collections containing Lyra Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Lyra Health is included in 9 Expert Collections, including Unicorns- Billion Dollar Startups.

U

Unicorns- Billion Dollar Startups

1,249 items

C

Conference Exhibitors

5,501 items

HLTH is a healthcare event bringing together startups and large companies from pharma, health insurance, business intelligence, and more to discuss the shifting landscape of healthcare

W

Wellness Tech

1,370 items

We define wellness tech as companies developing technology to help consumers improve their physical, mental, and social well-being. Companies in this collection play across a wide range of categories, including food and beverage, fitness, personal care, and corporate wellness.

D

Digital Health 50

300 items

The most promising digital health startups transforming the healthcare industry

F

Future Unicorns 2019

50 items

D

Digital Health

11,109 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

Lyra Health Patents

Lyra Health has filed 4 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/3/2016

5/18/2021

Natural language processing, Computational linguistics, Cognitive behavioral therapy, Medical terminology, Tasks of natural language processing

Grant

Application Date

6/3/2016

Grant Date

5/18/2021

Title

Related Topics

Natural language processing, Computational linguistics, Cognitive behavioral therapy, Medical terminology, Tasks of natural language processing

Status

Grant

Latest Lyra Health News

Clinical Effects of Asynchronous Provider-Guided Practice Sessions During Blended Care Therapy for Anxiety and Depression: Pragmatic Retrospective Cohort Study

Oct 18, 2024

Journal of Medical Internet Research This paper is in the following e-collection/theme issue: May 15, 2024 . Clinical Effects of Asynchronous Provider-Guided Practice Sessions During Blended Care Therapy for Anxiety and Depression: Pragmatic Retrospective Cohort Study Clinical Effects of Asynchronous Provider-Guided Practice Sessions During Blended Care Therapy for Anxiety and Depression: Pragmatic Retrospective Cohort Study Authors of this article: 2Department of Psychological Sciences, Northern Arizona University, Flagstaff, AZ, United States Corresponding Author: Abstract Background: Blended care therapy models are intended to increase the efficiency and effectiveness of evidence-based psychotherapy by combining synchronous and asynchronous components of care. Objective: This retrospective cohort study evaluated the clinical effects of synchronous video therapy sessions and asynchronous guided practice session elements on anxiety and depression in a blended care therapy program, with a novel focus on asynchronous provider feedback messages. Methods: Participants were adults (N=33,492) with clinical symptoms of anxiety (Generalized Anxiety Disorder 7-item scale [GAD-7] score of ≥8) and depression (Patient Health Questionnaire 9-item scale [PHQ-9] score of ≥10) at intake. Symptom trajectories were evaluated via individual growth curve models. Time-varying covariates evaluated effects of synchronous video session attendance and the presence or absence of each asynchronous guided practice session element occurring within 7 days and 8-14 days prior to each clinical outcome assessment. Guided practice session elements included client digital lesson completion, client digital exercise completion, and feedback messages sent by providers. Results: Approximately 86.6% (29,012/33,492) of clients met criteria for clinical improvement by end of care (median 6, IQR 4-8 synchronous sessions). Synchronous video session attendance and client digital lesson completion in the past 7 days and in the past 8-14 days were each uniquely and significantly associated with lower GAD-7 scores (video session effects: bsession7=–0.82, bsession8-14=–0.58, P values<.001; digital lesson effects: blesson7=–0.18, blesson8-14=–0.26, P values <.001) and PHQ-9 scores (video session effects: bsession7=–0.89, bsession8-14=–0.67, P values <.001; digital lesson effects: blesson7=–0.12, blesson8-14=–0.30, P values <.001). Client digital exercise completion in the past 8-14 days was significantly associated with lower GAD-7 scores (bexercise8-14=–0.10; P<.001) but exercise completion in the 7 days prior to clinical outcome assessment was not (bexercise7=0.00; P=.89). Exercise completion in the past 7 days was significantly associated with lower PHQ-9 scores (bexercise7=–0.16; P<.001) but exercise completion in the past 8-14 days was not (bexercise8-14=–0.05; P=.09). Provider feedback messaging in the past 7 days and in the past 8-14 days was significantly associated with lower GAD-7 and PHQ-9 scores, respectively (GAD-7: bfeedback7=–0.12, P<.001; bfeedback8-14=–0.07, P=.004; PHQ-9: bfeedback7=–0.15, P<.001; bfeedback8-14=–0.08, P=.01). Conclusions: Provider feedback between synchronous therapy sessions provided significant benefit for symptom reduction, beyond the effects of client digital engagement and synchronous video sessions. When guided practice sessions are well integrated into care, blended care therapy provides meaningful improvements upon the traditional, synchronous session–only therapy model. Provider guidance and feedback for clients between synchronous sessions support more efficient and effective mental health care overall. J Med Internet Res 2024;26:e60502 Introduction Evidence-based psychological treatments for anxiety and depression (eg, cognitive behavioral therapy) are highly effective in reducing symptoms and improving functioning [ 1 - 3 ]. These evidence-based psychotherapies include “active elements” such as therapy concepts, emotion regulation skills, and behavior change skills that impart unique therapeutic benefits [ 4 , 5 ]. Clients benefit from these active elements through a multistage process of provider sharing, client understanding, and client application of skills and concepts [ 5 ]. In traditional therapy models, therapists share or teach the active elements of these treatments solely during live, synchronous, once-weekly sessions. To fully benefit, clients must take in and understand this information as it pertains to their experience and then apply it independently via “homework” assignments that are completed between therapy sessions [ 5 ]. More consistent homework completion is associated with greater symptom reductions in psychotherapy [ 6 , 7 ]. However, multiple inefficiencies to this model have been identified. In the traditional model, clients often struggle to complete homework independently, with less than 40% of homework typically completed as assigned [ 8 , 9 ]. In addition, therapists follow up on homework with clients only approximately 50% of the time, which reduces opportunities to reinforce and consolidate client learning [ 10 , 11 ]. Without sufficient out-of-session skills practice, clients tend to experience suboptimal outcomes, including increased likelihood of premature treatment dropout, slower symptom improvements (presumably due to slower skills acquisition), and ultimately worse symptoms at end of care [ 7 , 12 - 14 ]. The traditional therapy model is therefore limited in the extent to which it supports client understanding, retention, and application of the skills and concepts that are necessary for treatment effectiveness [ 11 ]. Blended care therapy models have emerged as a potential solution to these challenges. These treatments bridge the gap between synchronous therapy sessions with asynchronous therapeutic engagement and digital content [ 15 ]. Preliminary evidence for blended care therapy models suggests that they can produce comparable or significantly better clinical outcomes in fewer live therapy sessions, relative to face-to-face psychotherapy [ 16 , 17 ]. Blended care therapy is an umbrella term that encompasses many treatment approaches. These approaches vary widely in the extent of asynchronous provider engagement between synchronous sessions, as well as the degree to which digital content is fully integrated into care [ 15 ]. This paper specifically examines a model of blended care therapy called “Lyra Care Therapy” (LCT). LCT blends synchronous video therapy sessions with intensive asynchronous guided practice sessions. In guided practice sessions, clients learn new evidence-based therapy concepts (beyond what is learned in synchronous sessions), receive messaging-based support from their providers, and apply therapy skills in their daily lives. Prior research on the LCT program has shown that this type of care is highly effective, with 89% of clients achieving either reliable improvement or recovery on validated outcome measures, and 74% achieving both reliable improvement and recovery [ 18 ]. This is substantially higher than the treatment response rates for depression found in standard, face-to-face mental health care settings. For example, a recent meta-analysis estimated that depression treatment response rates in “usual care” mental health treatment are approximately 20% [ 19 ]. LCT guided practice sessions contain multiple components, including digital video lessons, digital exercises, client message exchanges with their providers, and direct provider feedback to clients on their exercises. During synchronous sessions, providers set clients up for success by collaborating to select relevant and clinically appropriate digital activities to be completed. Clients then complete digital video lessons and exercises asynchronously during the guided practice session. Digital video lessons reinforce therapeutic skills taught in synchronous sessions or teach new concepts. Digital exercises then support clients in applying their newly learned skills in daily life, which is essential to facilitate symptom reductions [ 20 ]. Providers play a key role during LCT guided practice sessions by viewing clients’ progress on digital activities in the secure platform, sharing prompt feedback messages to reinforce clients’ efforts, and providing support through direct client-provider messaging. At their core, guided practice sessions offer a more engaging and effective alternative to traditional “homework” assignments in psychotherapy by facilitating asynchronous provider support and providing a more enriching digital experience for clients. Information from clients’ digital engagement also complements providers’ impressions from synchronous sessions to inform case conceptualization and care planning. Past research evaluating this specific blended care model has demonstrated its effectiveness for reducing symptoms of anxiety and depression, including across diverse racial and ethnic groups and in large samples of up to approximately 6000 participants [ 18 , 21 ]. A prior LCT component analysis study also provided preliminary support for the role of client engagement with guided practice sessions in improving symptoms [ 22 ]. However, this prior component analysis focused exclusively on client engagement and did not assess the role of provider engagement. In LCT, the provider also plays a key role in supporting guided practice, by curating what is assigned, providing positive reinforcement, answering client questions, and offering corrective feedback when needed. Prior results from research on homework effectiveness in evidence-based psychotherapies suggest that these provider-level factors may also contribute to therapy effectiveness [ 11 , 23 , 24 ]. In traditional therapy models, however, provider support is limited to in-session interactions. In contrast, LCT providers additionally give feedback and encouragement to their clients between synchronous sessions via written messages in the platform. Thus, clients can readily access them and apply the feedback to their daily lives. Although there is theoretical support for the importance of provider engagement in a blended care model, there is no known research evaluating the link between provider-specific digital engagement and clinical therapy outcomes. Therefore, a primary aim of this study was to explore the clinical impact of digital provider feedback in LCT, alongside client-focused engagement during guided practice sessions. We hypothesized that engagement with each element of the LCT program (ie, session attendance, client digital lesson completion, client digital exercise completion, and provider feedback) in the 7 days and 8-14 days prior to an outcome assessment would be associated with lower symptom severity at that assessment. Methods Study Design and Setting This observational study used a retrospective cohort design and is reported in line with guidelines for STROBE (Strengthening the Reporting of Observational Studies in Epidemiology; see Multimedia Appendix 1 for STROBE checklist). Participants were adults in the United States who were eligible for an employer-sponsored mental health benefit, Lyra Health, offered by Lyra Clinical Associates. Individuals seeking care completed a brief, questionnaire-based assessment via a secure web-based platform to evaluate baseline symptoms and recommend appropriate care. All care activities were conducted via a proprietary, HIPAA (Health Insurance Portability and Accountability Act)–compliant platform that is accessible via web browser and mobile device. Ethical Considerations This deidentified data analysis was determined to be exempt by the WCG institutional review board (WCG IRB Tracking ID#20220388). Participants provided informed consent to take part in care and have their deidentified data used for research purposes as a part of that consent for care. Data were collected as part of routine practice in the LCT program to support measurement-based clinical care and for quality assurance. Participants did not receive compensation for engagement with the LCT program or for completing assessments. Participants Individuals were eligible for this study if they began care on or after January 1, 2022, and completed or dropped out of care by November 5, 2023. This time frame was selected to allow for accumulation of a large sample size over nearly 2 years that was sufficiently representative and diverse to provide adequate statistical power to achieve study objectives. Participants were included if they had a baseline score in the clinical range on the Generalized Anxiety Disorder 7-item scale (GAD-7; total score of ≥8) [ 25 ] or Patient Health Questionnaire 9-item scale (PHQ-9; total score ≥10) [ 26 ]. Individuals were excluded from the study if they did not have a baseline assessment that was completed ≤2 weeks before their first session and before their second session; or they did not complete at least 1 follow-up assessment either during care or a maximum of 5 weeks after the date of the final session. See the participant flow diagram in Figure 1 for more detail. Consistent with prior research, only clinical outcome assessments and sessions occurring within 1 SD of the average therapy episode duration (16.85 weeks) were included in this study. ‎ Figure 1. Participant inclusion and exclusion. GAD-7: Generalized Anxiety Disorder—7-item scale; PHQ-9: Patient Health Questionnaire-9 item scale. Clinical Program Clinical Approach A detailed description of LCT has been provided in prior research [ 18 , 21 , 22 ]. Briefly, the program consists of synchronous video therapy sessions combined with asynchronous guided practice sessions (ie, digital activities assigned by providers, therapist feedback, and direct client-provider messaging) via a secure, web-based digital care platform. The platform is accessible via web browser and mobile app. The program uses evidence-based clinical approaches with the highest-quality scientific evidence (eg, cognitive behavioral therapy, dialectical behavior therapy, and acceptance and commitment therapy) and is grounded in culturally responsive care principles to meet the social identity-related needs of a diverse client population [ 21 , 27 - 29 ]. Providers and Clinical Quality Supervision Therapy is provided by licensed mental health professionals (eg, psychologists, marriage and family therapists, social workers, and professional counselors). Provider hiring is highly selective, emphasizing skillful use of evidence-based clinical practice and culturally responsive care. All providers receive >60 hours of intensive internal training upon hire, ongoing individual supervision, regular group consultation with a licensed clinical manager, and access to internal clinical consultation and training opportunities. Guided Practice Sessions Guided practice sessions refer to all interactions among the client, their provider, and the digital platform between synchronous sessions (see panels A and B in Figure 2 for illustrative examples of digital content). Two core elements of the guided practice sessions are digital video lessons and digital exercises. Lessons and exercises are based on evidence-based, transdiagnostic treatment approaches, including the Unified Protocol, dialectical behavior therapy, acceptance and commitment therapy, and other treatments rooted in cognitive behavioral principles [ 27 - 29 ]. Digital video lessons teach evidence-based therapeutic skills and concepts through a unique, narrative storytelling approach. Each lesson consists of 1-2 videos and concludes with a multiple-choice knowledge review to check clients’ comprehension. Digital exercises provide opportunities for clients to apply concepts and practice skills learned in therapy or in digital lessons and reflect on how these concepts apply to their daily lives. Providers have access to a large library of digital lessons and exercises for their clients, which apply to a range of presenting concerns. Providers collaborate with clients to select relevant and clinically appropriate digital activities for each guided practice session. Providers can also tailor activity instructions for each client. This process allows for personalization of guided practice sessions based on a client’s unique needs. Prior research has shown that use of these digital tools in LCT is associated with greater reductions in symptoms of anxiety and depression [ 22 , 30 ]. As clients complete their digital lessons and exercises, providers can view client progress and send asynchronous feedback messages. This provider feedback is intended to reinforce client learning and encourage consistent engagement for maximal clinical benefit [ 5 , 11 ]. The platform also allows for direct message exchanges between clients and providers. Through direct messages, clients can ask questions about their digital activities and ask their providers for help to troubleshoot challenges encountered when practicing skills. Providers can send check-in messages, answer questions, provide encouragement, and address any logistical or scheduling needs between sessions. Finally, all clients receive validated clinical outcome assessments throughout care to monitor treatment progress. Both providers and clients are able to view clients’ responses, assessment scores, and trends over time, which supports measurement-based care. ‎ Figure 2. Illustrative examples of the client digital interface. (A) Client home page in mobile app (client name and provider’s name and image are fictional). (B) Client view of the “Understanding emotions” digital lesson. Measures Demographic Characteristics, Session Attendance, and Treatment Duration Clients may optionally self-report race, ethnicity, and gender identity during the intake process. Participant age was documented as age in years at the time of the first synchronous video session. Session attendance was automatically tracked on the platform. Treatment duration was computed as the time in weeks between the first session and the last session. Digital Engagement During Guided Practice Sessions Engagement with each element of guided practice sessions (client digital lesson completion, client digital exercise completion, provider feedback messages, and client-provider direct messages) was recorded automatically in the platform. Clinical Outcome Measures For quality assurance and clinical assessment to support measurement-based care, all clients in the program received the PHQ-9 [ 26 ] and GAD-7 [ 31 ] on a weekly basis and after the final session. For the purposes of this manuscript, client responses to these assessments are referred to as clinical outcome assessments. Reliable improvement was defined as a reduction ≥6 on the PHQ-9 and ≥4 on the GAD-7 [ 32 , 33 ]. Recovery was defined by a final score <10 for the PHQ-9 and <8 for the GAD-7 [ 25 , 26 ]. Reliable improvement and recovery were evaluated only for the measures on which the baseline score was in the clinical range for a given client. If a client scored in the clinical range on both the GAD-7 and the PHQ-9, they were included in analyses for both measures (including growth curve modeling). Growth curve models used all available clinical outcome assessments for each participant, including but not limited to the first and last measurements completed within the data collection period (see “Participants” section for more information). Statistical Analysis All statistical analyses were performed in Python (version 3.10.9; Python Software Foundation) and R 4.2.3 (R Core Team) [ 34 ]. The statistical packages used for analyses are described in the remainder of the “Statistical Analysis” section where applicable. Overall Treatment Outcome Observed change in PHQ-9 and GAD-7 scores across the LCT episode was examined with 2-tailed dependent samples t tests, examining the difference between each individual’s baseline and last available clinical outcome assessments (a=.05). The SciPy package (version 1.10.0) was used for analysis [ 35 ]. Symptom Trajectories and Time-Varying Effects of Treatment Engagement Symptom change throughout the LCT episode was evaluated using linear mixed-effects models to fit individual growth curves for the PHQ-9 and GAD-7, respectively, using the lme4 package (version 1.1.35) and full-information restricted maximum likelihood estimation [ 36 ]. Data explorations were conducted to evaluate whether data missingness patterns for the clinical outcome assessments of interest were consistent with the missing at random assumption and are summarized in Multimedia Appendix 2 . Results were consistent with those expected if the missing at random assumption was met. For growth curve models, model 1 included linear and quadratic fixed effects for the continuous time variable (weeks). Participant-level random effects were estimated for the intercept, linear, and quadratic time components. In model 2, binary indicator variables (ie, absent=0, present=1) were used to model the time-varying effects of engagement with each treatment component (therapy sessions, client digital lesson completion, client digital exercise completion, and provider feedback messages) during the past 7 days. Direct messages were not included as a time-varying covariate (TVC) effect in growth curve models, because not all direct messages were expected to have therapeutic content and therefore their effects on clinical outcomes would be heterogeneous. In model 3, additional TVCs were added for treatment engagement over the prior 8-14 days. This modeling approach allowed for testing of whether engagement with each program element was uniquely associated with greater symptom reduction in the subsequent 1-2 weeks. Supplemental analyses were conducted using count variables for the treatment engagement TVCs, in place of the binary covariates used in the primary analysis. This would allow for testing of whether engagement with treatment components was associated with clinical outcomes in a linear manner, such that each additional engagement with the same treatment element in a given 1-2 weeks was associated with a fixed incremental benefit for symptom reduction. This approach is consistent with prior evaluations of this program but is limited in that it treats every digital element as an equal unit (ie, assumes a linear dose-response relationship). Findings from these analyses are reported in Multimedia Appendix 3 . An additional sensitivity analysis was conducted for the binary covariate models with participant demographics (age, gender identity, and race and ethnicity) added as fixed effects. Significant effects emerged for these covariates; however, addition of these variables provided only marginal improvement in model fit and did not change the pattern of results for the primary outcomes of interest. Results are reported in Multimedia Appendix 3 . Results Participant Characteristics A total of 33,492 clients were included in the sample (see Figure 1 for participant flow). Participants self-identified as Asian or Pacific Islander (5401/33,492, 16.1%), Black or African American (3026/33,492, 9.0%), Hispanic or Latino (3709/33,492, 11.1%), White (17,347/33,492, 51.8%), multiple identities (2687/33,492, 8.0%), or another identity (683/33,492, 2.0%). Participants self-reported their gender identities as female (21,217/33,492, 63.4%), male (10,547/33,492, 31.5%), nonbinary (295/33,492, 0.9%), and other identities (262/33,492, 0.8%). Nearly 9 in 10 participants (30,006/33,492, 89.5%) screened positive for anxiety on the GAD-7 [ 25 ] (score ≥8 at baseline), and nearly two-thirds (22,070/33,492, 65.9%) screened positive for depression on the PHQ-9 [ 26 ] (baseline score ≥10). See Table 1 for additional details on participant characteristics. Participants who were excluded due to insufficient clinical outcome assessment data were compared with included participants on baseline demographics, baseline clinical severity, and session count. As expected, given the large sample size, statistically significant differences were found, but effect sizes were very small for demographic and clinical variables (Cohen d=0.06-0.07, Cramer V=.02-.05). Notably, the median session count for the excluded group was 1 (IQR 1-2), which is much smaller than that for included participants (median 6, IQR 4-8). This indicates that most excluded clients did not continue therapy after attending the intake session (see Multimedia Appendix 4 for full results). Table 1. Participant characteristics. bPHQ-9: Patient Health Questionnaire 9-item scale. cN/A: not applicable; no participants scored in this range within the participant subsample. dTo be included in the anxiety sample, clients were required to have a GAD-7 score above the clinical cutoff of 8 or higher. The mild severity category was therefore split to distinguish between those above and below the clinical cutoff. Treatment Characteristics and Overall Clinical Outcome Participants attended a median of 6.0 live synchronous therapy sessions (IQR 4.0-8.0) over the course of a median of 8.0 (IQR 4.0-12.7) weeks. Participant engagement with digital tools during guided practice sessions was also high. Over the course of a therapy episode, participants viewed a median of 6.0 digital lessons (IQR 3.0-9.0), completed 6.0 exercises (IQR 2.0-12.0), and exchanged 16.0 direct messages (IQR 9.0-28.0) with their providers during guided practice sessions. In addition, participants received a median of 2.0 (IQR 0-4.0) feedback messages from their providers on their completed exercises. Descriptive statistics for engagement with all treatment components are detailed in Table 2 . Differences in symptom severity from the first to last clinical outcome assessment were evaluated via dependent samples t tests. Results indicated that participants experienced statistically significant reductions in symptoms of anxiety (n=30,006, t30,005=236.98; P<.001) and depression (n=22,070, t22,069=213.56; P<.001), as measured by the GAD-7 and PHQ-9, respectively, with very large observed effect sizes (Cohen d=1.37 for GAD-7; Cohen d=1.44 for PHQ-9). Furthermore, among the full sample, 86.6% (29,012/33,492) of participants experienced clinical improvement (defined as experiencing reliable improvement or recovery on the GAD-7, PHQ-9, or both) from their first to last assessment ( Table 3 ). Table 2. Session attendance and engagement with guided practice session elementsa. Treatment component 29,012 (86.62) aReliable improvement was defined by meeting at least one of the following criteria: (1) ≥4-point decrease on the final GAD-7 among those with baseline GAD-7 score of ≥8 and (2) ≥6-point decrease on the final PHQ-9 among those with baseline PHQ-9 score of ≥10. Recovery was defined by meeting at least one of the following criteria: (1) final GAD-7 score of <8 among those with baseline GAD-7 score of ≥8 and (2) final PHQ-9 score of <10 among those with baseline score of ≥10. bGAD-7: Generalized Anxiety Disorder 7-item scale. cPHQ-9: Patient Health Questionnaire 9-item scale. Anxiety Symptom Trajectories and Time-Varying Effects of Engagement Results from individual growth curve modeling for anxiety symptom trajectories and the time-varying effects of engagement with each program element are summarized in this section. Full modeling results are shown in Table 4 . Individuals with initial GAD-7 scores in the clinical range were included in the analysis (n=30,006). Coefficients from an initial model examined linear and quadratic fixed effects of time in weeks on GAD-7 scores (model 1). On average, participants exhibited an initial decline in anxiety symptoms of more than 1 unit per week (b=–1.23, 95% CI –1.24 to –1.22) that attenuated over time (b=0.06, 95% CI 0.06-0.06). Model 2 incorporated fixed effects for each TVC indicating the presence (or absence) of a given program element during the 7 days prior to the clinical outcome assessment. The occurrence of 1 or more synchronous video sessions was significantly associated with a –0.70 unit decrease in anxiety scores (b=–0.70, 95% CI –0.73 to –0.67). The coefficients for TVCs identifying client completion of 1 or more digital lessons (b=–0.20, 95% CI –0.24 to –0.17), client completion of 1 or more digital exercises (b=–0.13, 95% CI –0.17 to –0.09), and 1 or more provider feedback messages (b=–0.21, 95% CI –0.26 to –0.17) also indicated that these forms of client and provider engagement were uniquely and significantly associated with lower GAD-7 scores. A similar pattern emerged in model 3, which incorporated TVC effects during the 8-14 days prior to completion of the clinical outcome assessment. As expected, synchronous video session occurrence (b=–0.58, 95% CI –0.61 to –0.54), client digital lesson completion (b=–0.26, 95% CI –0.30 to –0.22), client digital exercise completion (b=–0.10, 95% CI –0.14 to –0.06), and the presence of provider feedback messaging (b=–0.07, 95% CI –0.12 to –0.02) were each significantly associated with lower GAD-7 scores. The pattern of findings for the 7-day coefficients was virtually unchanged from model 2, with the exception of the coefficient for exercise completion in the 7 days prior to a clinical outcome assessment. In model 2, the coefficient was larger, negative, and statistically significant, whereas in model 3, it was not statistically different from 0. Likelihood ratio tests across these models (all P values of <.01), as well as information criteria indices (Akaike information criterion [AIC] and Bayesian information criterion [BIC]), suggested that model 3 provided the best fit to the observed data. Panels A and B in Figure 3 depict the possible combinations of digital engagement and their expected impact on clinical symptoms in the 2 weeks leading up to the clinical outcome assessment, based on the coefficients from model 3. Table 4. Anxiety symptom trajectories and time-varying effects of engagement with elements of blended care therapya. Model 1 ‎ Figure 3. Estimated GAD-7 score reductions associated with different combinations of client and provider digital engagement in the (A) 0-7 days and (B) 8-14 days prior to a clinical outcome assessment. GAD-7: Generalized Anxiety Disorder-7 item scale. Depression Symptom Trajectories and Time-Varying Effects of Engagement Results from individual growth curve modeling for depression symptom trajectories and time-varying effects of engagement with each program element are summarized in this section. Full modeling results are reported in Table 5 . Participants with initial PHQ-9 scores in the clinical range were included in the analysis (n=22,070). Coefficients from an initial model examined linear and quadratic fixed effects of time in weeks on PHQ-9 scores (model 1). The coefficients in model 1 were consistent with a steep initial decline in depression symptoms of more than 1 unit per week (b=–1.45, 95% CI –1.46 to –1.43) that attenuated over time (b=0.07, 95% CI 0.07-0.07). The TVC effects in model 2 indicated that the occurrence of 1 or more synchronous video sessions during the previous week was associated with a –0.76 unit decrease in PHQ-9 scores (b=–0.76, 95% CI –0.80 to –0.72). Similarly, the past-week coefficients for client completion of 1 or more digital lessons (b=–0.14, 95% CI –0.19 to –0.10), client completion of 1 or more digital exercises (b=–0.31, 95% CI –0.36 to –0.26), and the occurrence of 1 or more provider feedback messages (b=–0.25, 95% CI –0.30 to –0.19) indicated that these forms of client and provider engagement were uniquely and significantly associated with lower PHQ-9 scores. In model 3, the coefficients for the occurrence of 1 or more synchronous video sessions (b=–0.67, 95% CI –0.71 to –0.62) 8-14 days prior to the clinical outcome assessment, as well as client completion of 1 or more digital lessons (b=–0.30, 95% CI –0.34 to –0.25), and the presence of feedback messaging from providers (b=–0.08, 95% CI –0.14 to –0.02), suggest that these forms of engagement are uniquely and significantly associated with lower PHQ-9 scores. In contrast, the coefficient for client digital exercise completion in the past 8-14 days was not significant (b=–0.05, 95% CI –0.10 to 0.01). The 7-day coefficients for therapy sessions, client lesson completion, and provider feedback messages were very similar across models 2 and 3. The coefficient for client exercise completion was numerically smaller relative to model 2 but still statistically significant (b=–0.15, 95% CI –0.21 to –0.10). Likelihood ratio tests across these models (all P values of <.01), as well as information criteria indices (AIC and BIC), suggested that model 3 provided the best fit to the observed data. Panels A and B in Figure 4 depict the possible combinations of digital engagement and their expected impact on clinical symptoms in the 2 weeks leading up to the clinical outcome assessment, based on the coefficients from model 3. Table 5. Depression symptom trajectories and time-varying effects of engagement with elements of blended care therapya. Model 1

Lyra Health Frequently Asked Questions (FAQ)

  • When was Lyra Health founded?

    Lyra Health was founded in 2015.

  • Where is Lyra Health's headquarters?

    Lyra Health's headquarters is located at 287 Lorton Avenue, Burlingame.

  • What is Lyra Health's latest funding round?

    Lyra Health's latest funding round is Series G.

  • How much did Lyra Health raise?

    Lyra Health raised a total of $906.13M.

  • Who are the investors of Lyra Health?

    Investors of Lyra Health include Coatue, Salesforce Ventures, Dragoneer Investment Group, Institutional Venture Partners, Sands Capital and 20 more.

  • Who are Lyra Health's competitors?

    Competitors of Lyra Health include Sanarai, Curio, Spring Health, Mindgram, Freespira and 7 more.

Loading...

Compare Lyra Health to Competitors

Modern Health Logo
Modern Health

Modern Health is a comprehensive global mental health solution provider in the healthcare industry. The company offers a range of services including one-on-one clinical therapy, group therapy sessions, and self-guided mental health resources designed to support the emotional, professional, social, financial, and physical well-being of employees. Modern Health primarily serves employers, consultants, health plans, and individuals seeking mental health benefits for their workforce or clients. Modern Health was formerly known as Modern Healthcare. It was founded in 2017 and is based in San Francisco, California.

Spring Health Logo
Spring Health

Spring Health specializes in providing mental health solutions within the healthcare sector. The company offers a range of services including personalized care plans, access to a network of mental health professionals, and support from dedicated Care Navigators, utilizing a proprietary assessment and machine-learning technology to tailor care to individual needs. Spring Health primarily serves the employer and health plan segments within the healthcare industry. It was founded in 2016 and is based in New York, New York.

Headspace Logo
Headspace

Headspace is a digital health company that focuses on mental wellness and mindfulness. It offers a suite of products, including guided meditations, sleep aids, and mindful movement exercises designed to improve mental health and well-being. The company primarily serves individuals seeking personal mental health support and organizations looking to enhance employee well-being. It was founded in 2010 and is based in Santa Monica, California.

Unmind Logo
Unmind

Unmind is a workplace wellbeing platform creating mentally healthy work environments across various sectors. The company offers tools and services to support mental health, utilizing a data-driven approach to provide personalized care and insights for organizational well-being strategies. Unmind primarily serves enterprises looking to enhance their employees' mental health and well-being. It was founded in 2016 and is based in London, United Kingdom.

Calm Logo
Calm

Calm operates as a mental wellness brand in the health and wellness industry. The company provides a digital platform for sleep, meditation, and relaxation, aimed at helping users manage stress, sleep better, and live healthier, happier lives. It primarily serves the corporate sector providing mental fitness and resilience as an employee benefit. It was founded in 2012 and is based in San Francisco, California.

Ieso Digital Health Logo
Ieso Digital Health

Ieso Digital Health focuses on digital mental healthcare and therapeutics within the healthcare industry. The company offers artificial-intelligence (AI)-powered, therapist-delivered digital behavioural therapy and develops clinically assessment and treatment products aimed at improving mental health outcomes. Ieso serves the healthcare sector, including partnerships with the UK National Health Service (NHS) and payers in the United States. Ieso Digital Health was formerly known as PsychologyOnline. It was founded in 2000 and is based in Cambridge, United Kingdom.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.